Nom du chef de service MICHELET Christian Mail christian.michelet@chu-Rennes.fr
Thématique 1 : infection à Staphylocoque aureus
Mots clés : SARM, ARN, virulence
Responsable scientifique : Brice FELDEN Mail
Intitulé de l’équipe : INSERM 835, fonction, structure et inactivation d’ARN bactériens
Encadrement de master ou thèse oui
Thématique 2 : Endocardite
Mots clés : endocardite, pharmacocinétique, épidémiologie
Responsable scientifique : Christian MICHELET Mail
Intitulé de l’équipe : service des Maladies infectieuses et tropicales
Encadrement de master ou thèse oui
Thématique 3 : infection par le VIH
Mots clés : cytopathie mictochondriale, co-infection VIH-VHC, traitement ARV
Responsable scientifique : Christian MICHELET Mail
Intitulé de l’équipe : service des Maladies infectieuses et tropicales
Encadrement de master ou thèse non
1. Long-term follow-up of methicillin-resistant Staphylococcus aureus molecular epidemiology after emergence of clone USA300 in San Francisco jail populations. Tattevin P, Diep BA, Jula M, Perdreau-Remington F. J Clin Microbiol. 2008 Dec;46(12):4056-7
2. Contribution of Panton-Valentine leukocidin in community-associated methicillin-resistant Staphylococcus aureus pathogenesis. Diep BA, Palazzolo-Ballance AM, Tattevin P, Basuino L, Braughton KR, Whitney AR, Chen L, Kreiswirth BN, Otto M, DeLeo FR, Chambers HF. PLoS ONE. 2008 Sep 12;3(9):e3198.
3. Alternative agents for the treatment of invasive infections due to methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to vancomycin. Tattevin P, Arvieux C, Michelet C. Arch Intern Med. 2007 Jun 11;167(11):1206
4. The use of drug resistance algorithms and genotypic inhibitory quotient in prediction of lopinavir-ritonavir treatment response in human immunodeficiency virus type 1 protease inhibitor-experienced patients. Maillard A, Chapplain JM, Tribut O, Bentué-Ferrer D, Tattevin P, Arvieux C, Michelet C, Ruffault A. J Clin Virol. 2007 Feb;38(2):131-8.
5. Antiviral activity, pharmacokinetics and safety of vicriviroc, an oral CCR5 antagonist, during 14-day monotherapy in HIV-infected adults. Schürmann D, Fätkenheuer G, Reynes J, Michelet C, Raffi F, van Lier J, Caceres M, Keung A, Sansone-Parsons A, Dunkle LM, Hoffmann C. AIDS. 2007 Jun 19;21(10):1293-9
6. What is the place of teicoplanin and linezolid in the treatment of prosthetic joint infections? Tattevin P, Arvieux C, Michelet C. Clin Microbiol Infect. 2006 Dec;12(12):1241-2
7. Increasing incidence of severe Epstein-Barr virus-related infectious mononucleosis: surveillance study. Tattevin P, Le Tulzo Y, Minjolle S, Person A, Chapplain JM, Arvieux C, Thomas R, Michelet C. J Clin Microbiol. 2006 May;44(5):1873-4
8. Respiratory manifestations of leptospirosis: a retrospective study. Tattevin P, Léveiller G, Flicoteaux R, Jauréguiberry S, Le Tulzo Y, Dupont M, Arvieux C, Michelet C. Lung. 2005 Jul-Aug;183(4):283-9
9. Use of high-performance liquid chromatography (HPLC) to monitor beta-lactam plasma concentrations during the treatment of endocarditis. Tattevin P, Tribut O, Arvieux C, Dupont M, Flicoteaux R, Desbordes L, Le Tulzo Y, Michelet C. Clin Microbiol Infect. 2005 Jan;11(1):76-9
10. Mitochondrial abnormalities in HIV-infected lipoatrophic patients treated with antiretroviral agents. Chapplain JM, Beillot J, Begue JM, Souala F, Bouvier C, Arvieux C, Tattevin P, Dupont M, Chapon F, Duvauferrier R, Hespel JP, Rochcongar P, Michelet C. J Acquir Immune Defic Syndr. 2004 Dec 1;37(4):1477-88
